Tweet Archive for March 2019 « page 14

RT @BrighamAERD: (2/2) In the study, patients were randomly assigned to receive either placebo or dupilumab for 24 weeks. Patients on dupil…

5:05pm Mar 10 2019 —

RT @BrighamAERD: (1/2) Exciting news for patients with #CRSwNP (& potentially #AERD)! Promising results of the Phase 3 trial for #dupilumab…

5:05pm Mar 10 2019 —

A case report – Blocking type 2 inflammation by dupilumab does not control classic (Type 1‐driven) allergic contact…

https://twitter.com/i/web/status/1104865701679022080

5:04pm Mar 10 2019 —

A drug not recognised as a photosensitiser? onlinelibrary.wiley.com/doi/10.1111/co… via Contact Dermatitis Jrnl @Wiley_Health…

https://twitter.com/i/web/status/1104864328572956672

4:59pm Mar 10 2019 —

RT @ducrest: #LupusAwareness –
What is lupus? resources.lupus.org/entry/what-is-…
Feinstein Institute Identifies Potential Cause for #Lupus https://t…

4:55pm Mar 10 2019 —

RT @ducrest: Discussion about the heterogeneous mechanisms involved in the pathogenesis of #lupus nephritis and how improved understanding…

4:55pm Mar 10 2019 —

5/ Diagnosis verywellhealth.com/what-is-lupus-…
6/ Treatment verywellhealth.com/what-is-lupus-…
7/ Coping verywellhealth.com/what-is-lupus-…
#lupus…

https://twitter.com/i/web/status/1104862541270921223

in reply to ducrest — 4:52pm Mar 10 2019 —

An Overview of Lupus
1/ The Immune System verywellhealth.com/what-is-lupus-…
2/ Types of Lupus verywellhealth.com/what-is-lupus-…
3/ Symp…

https://twitter.com/i/web/status/1104862539379367937

4:52pm Mar 10 2019 —

RT @MaraMihai2: A controversial subject: is it time to abandon #earlydetection #cancerscreening? “The future of population‐based #cancerscr…

9:43am Mar 10 2019 —

RT @ebmom: Nicky’s Life with Epidermolysis Bullosa UK Version pinterest.com/pin/1576260556…

3:11pm Mar 9 2019 —